{"id":"https://openalex.org/W2334026217","doi":"https://doi.org/10.1136/thoraxjnl-2011-201054c.255","title":"P255 ATTAIN: twice-daily aclidinium bromide in patients with moderate to severe chronic obstructive pulmonary disease","display_name":"P255 ATTAIN: twice-daily aclidinium bromide in patients with moderate to severe chronic obstructive pulmonary disease","alternate_titles":[],"publication_year":2011,"publication_date":"2011-12-01","ids":{"openalex":"https://openalex.org/W2334026217","doi":"https://doi.org/10.1136/thoraxjnl-2011-201054c.255","mag":"2334026217"},"language":"en","primary_location":{"id":"doi:10.1136/thoraxjnl-2011-201054c.255","doi":"https://doi.org/10.1136/thoraxjnl-2011-201054c.255","is_oa":true,"landing_page_url":"https://doi.org/10.1136/thoraxjnl-2011-201054c.255","pdf_url":"https://thorax.bmj.com/content/thoraxjnl/66/Suppl_4/A171.full.pdf","source":{"id":"https://openalex.org/S106546978","display_name":"Thorax","issn_l":"0040-6376","issn":["0040-6376","1468-3296"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thorax","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2334026217"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://thorax.bmj.com/content/thoraxjnl/66/Suppl_4/A171.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068917661","display_name":"Dave Singh","orcid":"https://orcid.org/0000-0001-8918-7075","observed_orcids":["https://orcid.org/0000-0001-8918-7075"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210151016","display_name":"Medicines Evaluation Unit","ror":"https://ror.org/05e497m36","country_code":"GB","type":"other","lineage":["https://openalex.org/I4210151016"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D. Singh","raw_affiliation_strings":["Medicines Evaluation Unit, University of Manchester, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicines Evaluation Unit, University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210151016"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107387136","display_name":"Peter M. Jones","orcid":"https://orcid.org/0000-0003-1201-2335","observed_orcids":["https://orcid.org/0000-0003-1201-2335"]},"institutions":[{"id":"https://openalex.org/I165862685","display_name":"St George's, University of London","ror":"https://ror.org/040f08y74","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I165862685","https://openalex.org/I4401726869"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P. W. Jones","raw_affiliation_strings":["St George's, University of London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St George's, University of London, London, UK","institution_ids":["https://openalex.org/I165862685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110508383","display_name":"Eric D Bateman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"E. D. Bateman","raw_affiliation_strings":["University of Cape Town, Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cape Town, Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054165025","display_name":"Alvar G.N. Agust\u00ed","orcid":"https://orcid.org/0000-0003-3271-3788","observed_orcids":["https://orcid.org/0000-0003-3271-3788"]},"institutions":[{"id":"https://openalex.org/I4210099160","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias","ror":"https://ror.org/0119pby33","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210099160","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"A. Agusti","raw_affiliation_strings":["Thorax Institute, Hospital Clinic, Barcelona, and CIBER Enfermedades Respiratorias and Fundaci\u00f3 Caubet-Cimera, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thorax Institute, Hospital Clinic, Barcelona, and CIBER Enfermedades Respiratorias and Fundaci\u00f3 Caubet-Cimera, Barcelona, Spain","institution_ids":["https://openalex.org/I4210099160","https://openalex.org/I4210115097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061494705","display_name":"Rosa Lamarca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"R. Lamarca","raw_affiliation_strings":["Almirall S.A., Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almirall S.A., Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014714297","display_name":"Gonzalo de Miquel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"G. de Miquel","raw_affiliation_strings":["Almirall S.A., Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almirall S.A., Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043800959","display_name":"Cynthia F. Caracta","orcid":"https://orcid.org/0000-0002-8841-873X","observed_orcids":["https://orcid.org/0000-0002-8841-873X"]},"institutions":[{"id":"https://openalex.org/I4391012632","display_name":"Forest Laboratories (United States)","ror":"https://ror.org/01p3wva84","country_code":"US","type":"company","lineage":["https://openalex.org/I4391012632"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Caracta","raw_affiliation_strings":["Forest Research Institute, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Forest Research Institute, New Jersey, USA","institution_ids":["https://openalex.org/I4391012632"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103930262","display_name":"Esther Garc\u00eda Gil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122008","display_name":"Almirall (Spain)","ror":"https://ror.org/03qsven24","country_code":"ES","type":"company","lineage":["https://openalex.org/I4210122008"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"E. Garcia Gil","raw_affiliation_strings":["Almirall S.A., Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almirall S.A., Barcelona, Spain","institution_ids":["https://openalex.org/I4210122008"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"66","issue":"Suppl 4","first_page":"A171","last_page":"A172"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aclidinium-bromide","display_name":"aclidinium bromide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.906000018119812},{"id":"https://openalex.org/keywords/long-acting-muscarinic-antagonist","display_name":"long-acting muscarinic antagonist","score":0.9739999771118164},{"id":"https://openalex.org/keywords/twice-daily-dosing","display_name":"twice-daily dosing","score":0.9919999837875366},{"id":"https://openalex.org/keywords/bronchodilation","display_name":"bronchodilation","score":0.7839999794960022},{"id":"https://openalex.org/keywords/fev1","display_name":"FEV1","score":0.906000018119812},{"id":"https://openalex.org/keywords/dyspnea","display_name":"dyspnea","score":0.7990000247955322},{"id":"https://openalex.org/keywords/acute-exacerbation-of-copd","display_name":"COPD exacerbations","score":0.8259999752044678},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.8519999980926514},{"id":"https://openalex.org/keywords/anticholinergic-adverse-events","display_name":"anticholinergic adverse events","score":0.9390000104904175},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8019999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9523905515670776},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.74171382188797},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.698982834815979},{"id":"https://openalex.org/C2780532441","wikidata":"https://www.wikidata.org/wiki/Q424294","display_name":"Ipratropium bromide","level":4,"score":0.6036655902862549},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.5529027581214905},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5243399739265442},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4989802837371826},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4659857153892517},{"id":"https://openalex.org/C55520419","wikidata":"https://www.wikidata.org/wiki/Q660995","display_name":"Vital capacity","level":5,"score":0.4637024998664856},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4455205798149109},{"id":"https://openalex.org/C111278954","wikidata":"https://www.wikidata.org/wiki/Q17069312","display_name":"Minimal clinically important difference","level":3,"score":0.420646071434021},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.32890403270721436},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3245267868041992},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.2271711826324463},{"id":"https://openalex.org/C2781018748","wikidata":"https://www.wikidata.org/wiki/Q927234","display_name":"Bronchodilator","level":3,"score":0.1288624107837677},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.1237027645111084},{"id":"https://openalex.org/C3018587741","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung function","level":3,"score":0.07093861699104309},{"id":"https://openalex.org/C165637977","wikidata":"https://www.wikidata.org/wiki/Q11067835","display_name":"Diffusing capacity","level":4,"score":0.06742286682128906},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/thoraxjnl-2011-201054c.255","doi":"https://doi.org/10.1136/thoraxjnl-2011-201054c.255","is_oa":true,"landing_page_url":"https://doi.org/10.1136/thoraxjnl-2011-201054c.255","pdf_url":"https://thorax.bmj.com/content/thoraxjnl/66/Suppl_4/A171.full.pdf","source":{"id":"https://openalex.org/S106546978","display_name":"Thorax","issn_l":"0040-6376","issn":["0040-6376","1468-3296"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thorax","raw_type":"journal-article"},{"id":"pmh:oai:open-archive.highwire.org:thoraxjnl:66/Suppl_4/A171","doi":null,"is_oa":false,"landing_page_url":"http://thorax.bmj.com/cgi/content/short/66/Suppl_4/A171","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":{"id":"doi:10.1136/thoraxjnl-2011-201054c.255","doi":"https://doi.org/10.1136/thoraxjnl-2011-201054c.255","is_oa":true,"landing_page_url":"https://doi.org/10.1136/thoraxjnl-2011-201054c.255","pdf_url":"https://thorax.bmj.com/content/thoraxjnl/66/Suppl_4/A171.full.pdf","source":{"id":"https://openalex.org/S106546978","display_name":"Thorax","issn_l":"0040-6376","issn":["0040-6376","1468-3296"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Thorax","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320332245","display_name":"Forest Laboratories","ror":"https://ror.org/03pfqk412"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2334026217.pdf","grobid_xml":"https://content.openalex.org/works/W2334026217.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2171697174","https://openalex.org/W1868950390","https://openalex.org/W2336565652","https://openalex.org/W2100215089","https://openalex.org/W2011096338","https://openalex.org/W2146803421","https://openalex.org/W2048517838","https://openalex.org/W2093844154"],"abstract_inverted_index":{"Introduction":[0],"and":[1,107,130,145,161,170,185,213,221,231,242,257],"Objectives":[2],"The":[3,60],"Phase":[4],"III":[5],"ATTAIN":[6],"study":[7,80,203],"investigated":[8],"the":[9,116,214,272],"effect":[10],"of":[11,16,93,132,153,216,274],"two":[12,125],"twice":[13,58,245],"daily":[14,246],"doses":[15],"aclidinium":[17,51,167],"bromide,":[18],"a":[19,96,265],"second-generation,":[20],"long-acting":[21],"muscarinic":[22],"antagonist":[23],"with":[24,30,180,264],"low":[25,220],"systemic":[26],"activity,":[27],"in":[28,67,72,89,100,158,226,251],"patients":[29,45,94,155],"moderate":[31],"to":[32,49,195,223,278],"severe":[33],"chronic":[34],"obstructive":[35],"pulmonary":[36,134],"disease":[37,135],"(COPD).":[38],"Methods":[39],"In":[40],"this":[41],"24-week,":[42],"double-blind":[43],"study,":[44],"were":[46,147,156,233],"randomised":[47],"(1:1:1)":[48],"receive":[50],"(200":[52],"\u03bcg,":[53],"400":[54,171,243],"\u03bcg)":[55],"or":[56],"placebo,":[57],"daily.":[59],"primary":[61],"endpoint":[62],"was":[63,192,210,219,261,276],"change":[64,86],"from":[65,87,177],"baseline":[66,88,178],"trough":[68,175],"forced":[69],"expiratory":[70],"volume":[71],"1":[73],"second":[74],"(FEV1)":[75],"at":[76,82,197],"Week":[77,165,198],"24.":[78],"Other":[79],"assessments":[81,204],"24":[83,199],"weeks":[84],"included:":[85],"peak":[90],"FEV1;":[91],"percentage":[92],"achieving":[95],"clinically":[97,248],"meaningful":[98,249],"improvement":[99],"St":[101],"George9s":[102],"Respiratory":[103,118],"Questionnaire":[104],"total":[105,152],"score":[106],"Transition":[108],"Dyspnoea":[109],"Index;":[110],"COPD":[111],"symptoms":[112],"as":[113],"assessed":[114],"by":[115],"EXACT":[117],"Symptoms":[119],"score;":[120],"exacerbation":[121,258],"rate":[122],"based":[123],"on":[124],"definitions":[126],"(healthcare":[127],"resource":[128],"utilisation":[129],"EXAcerbations":[131],"Chronic":[133],"Tool).":[136],"Adverse":[137],"events":[138],"(AEs),":[139],"clinical":[140],"laboratory":[141,227],"measures,":[142],"vital":[143,229],"signs":[144,230],"ECGs":[146,232],"also":[148],"assessed.":[149],"Results":[150],"A":[151],"819":[154],"included":[157],"intention-to-treat":[159],"(ITT)":[160],"safety":[162,267],"populations.":[163],"At":[164],"24,":[166],"200":[168,240],"\u03bcg":[169,172,241,244],"significantly":[173,193],"improved":[174],"FEV1":[176],"compared":[179],"placebo":[181,196],"(by":[182],"99":[183],"ml":[184],"128":[186],"ml,":[187],"respectively;":[188],"both":[189,270],"p<0.0001).":[190],"Aclidinium":[191,209,239,260],"superior":[194],"for":[200,269],"all":[201,236],"other":[202],"(Abstract":[205],"P255":[206],"table":[207],"1).":[208],"well":[211,262],"tolerated":[212,263],"incidence":[215,273],"anticholinergic":[217],"AEs":[218,275],"similar":[222,234,266,277],"placebo.":[224,279],"Changes":[225],"tests,":[228],"between":[235],"groups.":[237],"Conclusion":[238],"provided":[247],"improvements":[250],"bronchodilation,":[252],"health":[253],"status,":[254],"symptoms,":[255],"breathlessness":[256],"rate.":[259],"profile":[268],"doses;":[271]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2334026217","counts_by_year":[{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
